Pharmaceutical & API manufacturing sites in Singapore

32 drug establishments in Singapore are registered with the US FDA; 12 (38%) list API manufacture among their operations. 26 registrant companies are identified, 1 of them with more than one API site here; sites whose registrant is not resolved to a company profile are not counted. 10 published sites are matched to an EU or UK GMP certificate inspected within the last three years.

Counts are physical site addresses in the FDA's current establishment register (US-facing sites only), not headquarters and not production volume. Methodology

FDA-registered sites
32
Registered for API manufacture
12
Identified registrants
26
Current EU/UK GMP match
10

Registered operations

Drug manufacture21
Analytical testing21
API manufacture12
Labelling6
Packaging6
Sterilisation2
Relabelling2
Repackaging2
Particle size reduction1

A site can register several operations, so these do not add up to the site total.

Companies headquartered in Singapore

API manufacturing sites (12)

Other sites with EU/UK GMP documents (4)

Only sites registered with the US FDA appear, so manufacturing that serves only other markets is missing and these figures understate national capacity. A GMP match requires the certificate address to name the site's street and its city or postcode; an unmatched site is not an uncertified site.